News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Press releases

2018

22 August, 2018 Half-Year Report January-June 2018 News English Regulatory MAR Report Interim Q2 IR Optional
15 August, 2018 Delivery of study drug to the PledOx® phase III program is expected in September News English Regulatory IR Optional
24 April, 2018 Interim Report January-March 2018 News English Regulatory MAR Report Interim Q1 IR Optional
Previous

Calendar and upcoming reports

December 18, 2024
Investor Day (Stockholm & online)

February 26, 2025
Year-end Report Q4 2024 (7:00am CET)

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: [email protected]